Hormone replacement therapy and mammographic screening.
作者信息
Marsden Jo
机构信息
King's College Hospital, Denmark Hill, London SE5 9RS, UK.
出版信息
J Br Menopause Soc. 2004 Jun;10(2):75, 80. doi: 10.1258/136218004774202391.
PMID:15207029
Abstract
摘要
相似文献
1
Hormone replacement therapy and mammographic screening.
J Br Menopause Soc. 2004 Jun;10(2):75, 80. doi: 10.1258/136218004774202391.
2
The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
J Clin Oncol. 2005 May 20;23(15):3636-7; author reply 3637-8. doi: 10.1200/JCO.2005.05.378.
3
[The role of progestin in menopausal hormonal replacement therapy].
Duodecim. 1996;112(12):1097-103.
4
[Results of mammographic screening and organizational aspects].
Ann Ostet Ginecol Med Perinat. 1989;Spec No:101-13.
5
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Cancer. 2003 Oct 1;98(7):1552-3; author reply 1553. doi: 10.1002/cncr.11697.
6
[HRT debate (hormone replacement therapy in menopause)].
Bull Cancer. 2000 Jul;87(7-8):522-4.
7
Hormone replacement therapy: the right choice for your patient?
J Fam Pract. 2005 May;54(5):428-36.
8
Hormone therapy is no heart helper. The latest chapter in the sage of hormone replacement therapy warns that it may harm, not help, the heart.
Harv Heart Lett. 2002 Oct;13(2):2-3.
9
[Postmenopausal hormone therapy].
Duodecim. 2006;122(5):529-32.
10
Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
BMJ. 2004 May 29;328(7451):1291-2. doi: 10.1136/bmj.328.7451.1291.
Zotero 插件